Protherics PLC
Notification of Major Interests in Shares
London, UK; Brentwood, TN, US: 26 July 2007 - Protherics PLC ("Protherics" or
the "Company"), the international biopharmaceutical company focused on critical
care and cancer, announces that, on 24 July 2007, a notification of interest in
the ordinary share capital of the Company was received from AXA Investment
Managers UK Limited on behalf of AXA S.A. and its Group companies, in accordance
with the Transparency Obligations Directive. Details of their interest are as
follows:
1. Reason for the notification (please tick the appropriate box or boxes)
An acquisition or disposal of voting rights x
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):
2. Full name of person(s) subject to the
notification obligation:
AXA S.A., 25 Avenue Matignon, 75008 Paris and its
group of companies.
3. Full name of shareholder(s) (if different
from 2.):
4. Date of the transaction (and date on which
the threshold is crossed or reached if
different):
23 July 2007
5. Date on which issuer notified:
24 July 2007
6. Threshold(s) that is/are crossed or reached:
10%
7. Notified details:
A: Voting rights attached to shares
Class/type of Situation previous to Resulting situation after the triggering transaction
shares the Triggering
transaction
if possible using Number of Number of Number of Number of voting rights % of voting rights
the ISIN CODE Shares Voting shares
Rights Direct Direct Indirect Direct Indirect
GB0007029209 33,389,110 33,389,110 340,879 340,879 34,627,202 0.10% 10.21%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration date Exercise/ Conversion Number of voting rights % of voting rights
instrument Period/ Date that may be acquired if
the instrument is
exercised/ converted.
Total (A+B)
Number of voting rights % of voting rights
34,968,081 10.31%
8. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable :
Name of Company/Fund Number of Shares % of issued share capital
AXA UK Investment Co ICVC 1,121,588 0.33062
UK Smaller Companies Fund
Indirect
Sun Life Pensions Management Ltd 11,250 0.00332
Direct
Sun Life Unit Assurance Ltd 53,913 0.01589
FTSE All Share Tracker
Direct
Sun Life Pensions Management 275,716 0.08128
FTSE All Share Tracker
Direct
AXA Framlington 15,013,453 4.42568
UK Select Ops
Indirect
AXA Framlington 13,753,131 4.05416
Equity Income
Indirect
AXA Framlington 1,267,498 0.37363
Health
Indirect
AXA Framlington 1,692,599 0.49895
Managed Balanced
Indirect
AXA Framlington 394,259 0.11622
BAE Systems Pensions Fund CIF Trustees
Indirect
AXA Framlington 176,049 0.05190
BAE Systems 2000 Pensions Fund
Indirect
Framlington onshore private clients 1,152,375 0.33970
Indirect
Framlington onshore private clients 56,250 0.01658
Indirect
Total Direct 340,879 0.10048
Total Indirect 34,627,202 10.20745
TOTAL 34,968,081 10.30793
Proxy Voting:
9. Name of the proxy holder:
10. Number of voting rights proxy holder will cease to hold:
11. Date on which proxy holder will cease to hold voting
rights:
12. Additional information:
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Anna Keeble +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
Protherics PLC announces Holding(s) in Company
| Source: Protherics PLC
Cheshire, UK--(Marketwire - July 26, 2007) -